The probiotic Escherichia coli strain Nissle 1917 interferes with invasion of human intestinal epithelial cells by different enteroinvasive bacterial pathogens

FEMS Immunology and Medical Microbiology

Volumn 40, Issue 3, 2004, Pages 223-229

  Altenhoefer, Artur ^a   Oswald, Sibylle ^a   Sonnenborn, Ulrich ^b   Enders, Corinne ^b   Schulze, Juergen ^b   Hacker, Joerg ^a   Oelschlaeger, Tobias A ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b Ardeypharm GmbH   (Germany)

Author keywords

Escherichia coli Nissle 1917; Invasion; Listeria; Probiotic; Salmonella

Indexed keywords

MUTAFLOR; PROBIOTIC AGENT; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL CELL; BACTERIAL INFECTION; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; CELL INVASION; CELL VIABILITY; CONTROLLED STUDY; EMBRYO; ESCHERICHIA COLI; ESCHERICHIA COLI NISSLE 1917; HUMAN; HUMAN CELL; INHIBITION KINETICS; INTESTINE CELL; LEGIONELLA PNEUMOPHILA; LISTERIA MONOCYTOGENES; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; SALMONELLA; SHIGELLA FLEXNERI; YERSINIA ENTEROCOLITICA;

ANTIBIOSIS; BACTERIA; BACTERIOCINS; CELL LINE; EPITHELIAL CELLS; ESCHERICHIA COLI; HUMANS; INTESTINAL MUCOSA; LEGIONELLA PNEUMOPHILA; LISTERIA MONOCYTOGENES; PROBIOTICS; SALMONELLA TYPHIMURIUM; SHIGELLA FLEXNERI; YERSINIA ENTEROCOLITICA;

EID: 1642374075     PISSN: 09288244     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0928-8244(03)00368-7     Document Type: Article

References (35)

1. Berg R.D. Probiotics, prebiotics or 'conbiotics'? Trends Microbiol. 6:1998;89-92.
2. Saarela M., Lähteenmäki L., Crittenden R., Salminen S., Mattila-Sandholm T. Gut bacteria and health foods - the European perspective'. Int. J. Food Microbiol. 78:2002;99-117.
3. Reid G., Howard J., Gan B.S. Can bacterial interference prevent infection? Trends Microbiol. 9:2001;424-428.
4. Elmer G.W. Probiotics: 'Living drugs'. Am. J. Health Syst. Pharm. 58:2001;1101-1109.
5. Kruis W., Schütz E., Fric P., Fixa B., Judmaier G., Stolte M. Double-blind comparison of an oral Escherichia coli preparation and mesalazine in maintaining remission of ulcerative colitis. Aliment. Pharmacol. Ther. 11:1997;853-858.
6. Rembacken B.J., Snelling A.M., Hawkey P.M., Chalmers D.M., Axon A.T. Non-pathogenic Escherichia coli versus mesalazine for the treatment of ulcerative colitis: a randomised trial. Lancet. 354:1999;635-639.
7. Cukrowska B., Lodinova-Zadnikova R., Enders C., Sonnenborn U., Schulze J., Tlaskalova-Hegenova H. Specific proliferative and antibody respsonses of premature infants to intestinal colonization with nonpathogenic probiotic E. coli strain Nissle 1917. Scand. J. Immunol. 55:2002;204-209.
8. Lodinova-Zadnikova R., Sonnenborn U. Effect of preventive administraion of a nonpathogenic Escherichia coli strain on the colonization of the intestine with microbial pathogens in newborn infants. Biol. Neonate. 71:1997;224-232.
9. Lodinova-Zadnikova R., Slavikova M., Tlaskalova-Hogenova H., Adlerberth I., Hanson L.A., Wold A., Carlson B., Svanborg C., Mellander L. The antibody response in breast-fed and non-breast-fed infants after artificial colonization of the intestine with Escherichia coli O83. Pediatr. Res. 29:1991;396-399.
10. Figueiredo P.P., Vieira E.C., Nicoli J.R., Nardi R.D., Raibaud P., Duval-Iflah Y., Penna F.J. Influence of oral inoculation with plasmid-free human Escherichia coli on the frequency of diarrhea during the first year of life in human newborns. J. Pediatr. Gastroenterol. Nutr. 33:2001;70-74.
11. Blum G., Marre R., Hacker J. Properties of Escherichia coli strains of serotype O6. Infection. 23:1995;234-236.
12. Grozdanov L., Zähringer U., Blum-Oehler G., Brade L., Henne A., Knirel Y.A., Schombel U., Schulze J., Sonnenborn U., Gottschalk G., Hacker J., Rietschel E.T., Dobrindt U. A single nucleotide exchange in the wzy gene is responsible for the semirough O6 lipopolysaccharide phenotype and serum sensitivity of Escherichia coli strain Nissle 1917. J. Bacteriol. 184:2002;5912-5925.
13. Blum-Oehler G., Oswald S., Eiteljörge K., Sonnenborn U., Schulze J., Kruis W., Hacker J. Development of strain-specific PCR reactions for the detection of the probiotic Escherichia coli strain Nissle 1917 in fecal samples. Res. Microbiol. 154:2003;59-66.
14. Klaenhammer T.R. Bacteriocins of lactic acid bacteria. Biochimie. 70:1988;337-349.
15. Klaenhammer T.R. Genetics of bacteriocins produced by lactic acid bacteria. FEMS Microbiol. Rev. 12:1993;39-86.
16. Baquero F., Moreno F. The microcins. FEMS Microbiol. Lett. 23:1984;117-124.
17. Papavassiliou J. Biological characteristics of colicine X. Nature. 190:1961;110.
18. Papavassiliou J. Production of colicines in Simmons's citrate agar. Nature. 184:1959;1339-1340.
19. Neish A.S., Gewirtz A.T., Zeng H., Young A.N., Hobert M.E., Karmali V., Rao A.S., Madara J.L. Prokaryotic regulation of epithelial responses by inhibition of IkappaB-alpha ubiquitination. Science. 289:2000;1560-1563.
20. Hooper L.V., Xu J., Falk P.G., Midtvedt T., Gordon J.I. A molecular sensor that allows a gut commensal to control its nutrient foundation in a competitive ecosystem. Proc. Natl. Acad. Sci. USA. 96:1999;9833-9838.
21. Hooper L.V., Wong M.H., Thelin A., Hansson L., Falk P.G., Gordon J.I. Molecular analysis of commensal host-microbial relationships in the intestine. Science. 291:2001;881-884.
22. Isolauri E. Probiotics for infectious diarrhea. Gut. 52:2003;436-437.
23. Patzer S.I., Baquero M.R., Bravo D., Moreno F., Hantke K. Microcins M and H47, which might utilize the catecholate siderophore receptors FepA, Cir, Fiu and IroN. Microbiology. 149:2003;2557-2570.
24. Oswald, S. et al., manuscript in preparation.
25. Datsenko K.A., Wanner B.L. One-step inactivation of chromsomal genes in Escherichia coli K-12 using PCR products. Proc. Natl. Acad. Sci. USA. 97:2000;6640-6645.
26. Hynes M.F., Quandt J., O'Connell M.P., Puhler A. Direct selection for curing and deletion of Rhizobium plasmids using transposons carrying the Bacillus subtilis sacB gene. Gene. 78:1989;111-120.
27. Feeley J.C., Gibson R.J., Gorman G.W., Langford N.C., Rasheed J.K., Makel D.C., Baine W.B. Charcoal-yeast extract agar: primary isolation medium for Legionella pneumophila. J. Clin. Microbiol. 10:1979;437-441.
28. Oelschlaeger T.A., Tall B.D. Invasion of cultured human epithelial cells by Klebsiella pneumoniae isolated from the urinary tract. Infect. Immun. 65:1997;2950-2958.
29. Mandel, L., Trebichavsky, I., Splichal, I. and Schulze, J. (1995) Stimmulation of intestinal immune cells by E. coli in gnotobiotic piglets. In: Advances in Mucosal Immunology (Mestecky, J., Ed.), pp 463-464. Plenum Press, New York.
30. Hudault S., Guignot J., Servin A.L. Escherichia coli strains colonising the gastrointestinal tract protect germfree mice against Salmonella typhimurium infection. Gut. 49:2001;47-55.
31. Bernet M.F., Brassart D., Neeser J.R., Servin A.L. Lactobacillus acidophilus LA1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut. 35:1994;483-489.
32. Bernet-Camard M.F., Lievin V., Brassart D., Neeser J.R., Servin A.L., Hudault S. The human Lactobacillus acidophilus strain LA1 secretes a nonbacteriocin antibacterial substance(s) active in vitro and in vivo. Appl. Environ. Microbiol. 63:1997;2747-2753.
33. Hudault S., Lieven V., Bernet-Camard M.-F., Servin A.L. Antagonistic activity excerted in vitro and in vivo by Lactobacillus casei (strain GG) against Salmonella typhimurium C5 infection. Appl. Environ. Microbiol. 63:1997;513-518.
34. Tuomola E.M., Ouwehand A.C., Salminen S.J. The effect of probiotic bacteria on the adhesion of pathogens to human intestinal mucus. FEMS Immunol. Med. Microbiol. 26:1999;137-142.
35. Mack D.R., Michail S., Wei S., McDougall L., Hoolingworth M.A. Probiotics inhibit enteropathogenic E. coli adherence in vitro by inducing intestinal mucin gene expression. Am. J. Physiol. 276:1999;G941-G950.